Dr. Fuh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-3181Fax+1 314-362-8644- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gynecologic Oncology, 2009 - 2012
- Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
- Georgetown University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2022 - 2024
- MO State Medical License 2013 - 2024
- IL State Medical License 2022 - 2023
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsGeneration and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids.Olivia Graham, Jeimmy Rodriguez, Lillian van Biljon, Bisiayo Fashemi, Emily Graham, Katherine Fuh, Dineo Khabele, Mary Mullen> ;Journal of Visualized Experiments. 2023 Jan 6
- Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery.Abigail S Zamorano, Angela L Mazul, Christine Marx, Mary M Mullen, Molly Greenwade, L Stewart Massad, Carolyn K McCourt, Andrea R Hagemann, Premal H Thaker, Katherine ...> ;Gynecologic Oncology Reports. 2022 Dec 1
- 1 citationsGynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention.Sarah P Huepenbecker, Sophia Lewis, Mark C Valentine, Marguerite L Palisoul, Premal H Thaker, Andrea R Hagemann, Carolyn K McCourt, Katherine C Fuh, Matthew A Powell, ...> ;Gynecologic Oncology Reports. 2022 Oct 1
- Join now to see all
Journal Articles
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerIan S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous CancerIan S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
Press Mentions
- Aravive to Host Virtual KOL Event on Its Late-Stage Oncology Asset BatiraxceptMay 8th, 2023
- Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian CancerJanuary 4th, 2023
- Gynecologic Cancer Clinicians and Researchers Recognized at SGO 2022 Annual Meeting on Women’s CancerMarch 21st, 2022
- Join now to see all
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: